JMI Hospital Requisite Manufacturing LimitedJHRMLCategory B

News & announcements

• Tue, 3rd November 2026 12:44 pm
  Board Meeting schedule under LR 16(1)

  As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2026 at 3:30 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.
• Mon, 2nd November 2026 04:12 pm
  Sale Declaration of a Nominated Director

  Mr. Ranjit Chakraborty, a Nominated Director (nominated by JMI Vaccine Ltd.) of the Company, has expressed his intention to sell his entire holding of 29,634 shares of the Company at the prevailing market price in the public market through Dhaka Stock Exchange PLC. (DSE) within next 30 working days.
• Wed, 28th October 2026 10:05 am
  Dividend Declaration

  The Board of Directors has recommended 2.50% Cash Dividend only for General Shareholders excluding Sponsors & Directors for the year ended June 30, 2026. The quantity of securities held by the said sponsors and/or directors: 4,04,64,500 shares. The amount payable to the general shareholders is Tk. 2,12,07,405. Date of AGM: 24 January 2027, Time: 11:00 AM, Venue: The AGM venue details will be conveyed through the AGM notice. Record Date: November 26, 2026. (cont.)
• Wed, 28th October 2026 10:05 am
  Dividend Declaration

  (Cont. news of JHRML): The Company has also reported consolidated EPS of Tk. 0.71, consolidated NAV per share of Tk. 35.51 and consolidated NOCFPS of Tk. 0.35 for the year ended June 30, 2026 as against consolidated EPS of Tk. 1.86, consolidated NAV per share of Tk. 35.14 and consolidated NOCFPS of Tk. 2.33 for the year ended June 30, 2025. (end)
• Wed, 28th October 2026 10:05 am
  Price Limit Open

  There will be no price limit on the trading of the shares of the Company today (28.10.2026) following its corporate declaration.
• Wed, 14th October 2026 12:05 pm
  Board Meeting schedule under LR 19(1)

  As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2026 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2026.
• Sun, 23rd August 2026 02:04 pm
  Auditor's report regarding status of IPO Proceeds utilization

  JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the Period from 01 April 2026 to 30 June 2026. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/JMI%20Hospital826.pdf
• Wed, 20th May 2026 04:02 pm
  Auditor's report regarding status of IPO Proceeds utilization

  JMI Hospital Requisite Manufacturing Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the period from 01 January 2026 to March 31, 2026. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/JMI26.pdf
• Wed, 29th April 2026 10:05 am
  Q3 Financials

  (Q3 Un-audited): Consolidated EPS was Tk. 0.18 for January-March 2026 as against Tk. 0.50 for January-March 2025; Consolidated EPS was Tk. 0.67 for July 2025-March 2026 as against Tk. 1.56 for July 2024-March 2025. Consolidated NOCFPS was Tk. 0.29 for July 2025-March 2026 as against Tk. 0.75 for July 2024-March 2025. Consolidated NAV per share was Tk. 35.47 as on March 31, 2026 and Tk. 35.14 as on June 30, 2025. (cont.)
• Wed, 29th April 2026 10:05 am
  Q3 Financials

  (Cont. News of JHRML): Reasons for Deviation: EPS has decreased because imported raw materials purchases are at high prices compared with sales in the local market (end)
• Sun, 19th April 2026 01:29 pm
  Board Meeting schedule under LR 16(1)

  As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.
• Tue, 24th February 2026 12:45 pm
  Dividend Disbursement

  The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
• Mon, 2nd February 2026 04:31 pm
  Auditor's report regarding status of IPO Proceeds utilization

  JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the period from 01 October 2025 to 31 December, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JMI%20Hospital%20Requisite_25.pdf
• Wed, 28th January 2026 10:04 am
  Q2 Financials

  (Q2 Un-audited): Consolidated EPS was Tk. 0.21 for October-December 2025 as against Tk. 0.51 for October-December 2024; Consolidated EPS was Tk. 0.49 for July-December 2025 as against Tk. 1.06 for July-December 2024. Consolidated NOCFPS was Tk. 0.29 for July-December 2025 as against Tk. 0.36 for July-December 2024. Consolidated NAV per share was Tk. 35.63 as on December 31, 2025 and Tk. 35.14 as on June 30, 2025. (cont.)
• Wed, 28th January 2026 10:04 am
  Q2 Financials

  (Cont. News of JHRML): Reasons for deviation: EPS decreased because imported raw material purchases are at high prices compared with sales in the local market. (end)